Phosphocholine

Phosphocholine

SCHEMBL3963371

CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCCCC.C[N+](C)(C)CCOP(=O)([O-])O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.74
NR5A2 O00482 1/20 0.74
NR5A1 Q13285 1/20 0.74
FABP3 P05413 1/20 0.72
MAPT P10636 1/20 0.65
PRKCA P17252 4/20 0.64
PRKCE Q02156 2/20 0.64
PRKCQ Q04759 2/20 0.64
PRKCD Q05655 2/20 0.64
LPAR3 Q9UBY5 6/20 0.58
LPAR1 Q92633 3/20 0.58
ENPP2 Q13822 3/20 0.58
RECQL P46063 1/20 0.57
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
LPAR2 Q9HBW0 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,2-Dipalmitin SCHEMBL4326807 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL18114342 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL3803615 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL1422042 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL18114371 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL3654560 1.00 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL18114373 0.94 PRKCA (0.68) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Diolein SCHEMBL3652589 0.94 PRKCA (0.68) SMN1; SMN2NR5A2NR5A1FABP3MAPT
Phosphocholine SCHEMBL18114339 0.94 PRKCA (0.68) SMN1; SMN2NR5A2NR5A1FABP3MAPT
1,2-Dipalmitin SCHEMBL17223985 0.92 SMN1; SMN2 (0.74) SMN1; SMN2NR5A2NR5A1FABP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009129387-A2 CATIONIC LIPIDS AND USES THEREOF ABBOTT LABORATORIES (US) 2009-10-22 WO claimed
WO-2016156330-A1 SOLID PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS SOFOSBUVIR AND A PHOSPHOLIPID RATIOPHARM GMBH (DE) 2016-10-06 WO disclosed